Type 2 Diabetes Trial, Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
For the main participant (person with diabetes):
- Adults who are 65 years of age or older at the time they agree to join the study
- People who are actively receiving care at a UNC Health or UNC Physicians Network clinic, meaning they have had 2 or more visits in primary care, family medicine, internal medicine, geriatrics, or endocrinology clinics in the past year, and who live within 90 miles of UNC Main Hospital in Chapel Hill, NC
- People who are currently using any type of insulin
- People who have not used a continuous glucose monitor (a small wearable device that tracks blood sugar levels) in the past year
- People who are willing to use a smartphone to view their blood sugar readings through an app
- People who are fluent in English
For a care partner (optional, someone who supports the main participant):
- Someone who lives in the same household as the main study participant
- Someone who is 18 years of age or older
- Someone who is fluent in English
- Someone who is willing to attend study sessions alongside the main participant and learn how to better support them in managing diabetes
- Someone who agrees to have study sessions recorded
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
For the main participant:
- People who have a clinical diagnosis of dementia (mild cognitive impairment that does not meet the full diagnosis of dementia may still be acceptable — confirm with trial site)
- People who are currently receiving dialysis
- People with severe vision or hearing difficulties that would prevent them from using the glucose monitoring device or taking part in group sessions held in person or online
- People with a significant medical or psychiatric condition, or who are taking a medication, that the study doctor believes could affect their ability to complete the study, or where life expectancy may be less than one year (confirm with trial site)
- People who are not available for the full 6-week study period, for example due to planned surgery, a procedure, or a vacation, or who are unwilling to follow study procedures
- People who are not fluent in English
- People who do not agree to have study sessions recorded
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Anna Kahkoska, MD, PhD, University of North Carolina, Chapel Hill
Phone: 919-843-9977
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
CGM Wear Time; CGM Use at 6 Weeks
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.